U.S. Pharmacist eNewsletter
September 2021


Study Examines mRNA Vaccines' Effectiveness Against Severe COVID-19 Outcomes

As the pandemic continues, it is imperative that clinicians understand how efficacy assessments from clinical trials of COVID-19 vaccines compare with available data. Results from a recent study demonstrated that two doses of the available messenger RNA (mRNA) vaccines are extremely effective in preventing symptomatic infections and in diminishing the incidence of hospitalizations and death. Read more.

Advertisement

Study Sheds Light on Real-World mRNA Vaccine Effectiveness
A recently published study in the Annals of Internal Medicine indicates that the currently available mRNA vaccines are very effective in averting confirmed infection in a high-risk population of U.S. veterans in a real-world setting. Read more.





Study: COVID-19 Vaccination Protects Solid Organ–Transplant Recipients
Data from two studies have shown reduced antibody responses to COVID-19 in solid-organ transplant recipients and a variable effect on T-cell responses. As a result, researchers studied the clinical effectiveness and breakthrough infections in vaccinated transplant patients. Findings from a new study suggest the potential protective benefits of COVID-19 vaccination in solid organ–transplant recipients. Read more.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App
Advertisement